What is the management approach for acute poison ingestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Poison Ingestion

Immediately prioritize airway, breathing, and circulation support following standard BLS/ACLS protocols, as cardiac arrest from poisoning is managed identically to other causes of arrest with few exceptions for toxin-specific interventions during resuscitation. 1

Immediate Life-Threatening Interventions

Resuscitation Priorities

  • Implement life-support measures first: cardiopulmonary resuscitation for cardiac arrest, respiratory support for inadequate ventilation, and left lateral head-down positioning with IV glucose for unconscious patients 2, 3
  • Call emergency medical services immediately in life-threatening situations and contact poison control center (1-800-222-1222 in US; 1-800-268-9017 in Canada) for expert guidance 1, 2
  • Transport via ambulance with continuous monitoring for patients requiring emergency department referral 4, 5, 6

Critical Symptom Management

  • Administer benzodiazepines (diazepam or midazolam) for seizures, status epilepticus, or severe agitation (Class I recommendation) 2, 3, 4
  • Give atropine for severe bradycardia from organophosphate/carbamate poisoning 2
  • Elevate legs for hypotension and administer vasopressors as needed 7
  • Administer naloxone 0.2-2 mg IV/IO/IM for opioid-induced respiratory depression, titrating to restore respiratory drive and protective airway reflexes, not full consciousness 1, 2, 3

Gastrointestinal Decontamination

Activated Charcoal

  • Administer activated charcoal within 1-2 hours of ingestion if the patient ingested a potentially toxic amount of a substance known to be adsorbed by charcoal 1, 3
  • Patient must be fully conscious with intact airway protective reflexes 3, 5
  • Do NOT give activated charcoal for caustic substances (acids/alkalis), metals, or hydrocarbons 1
  • Do not delay emergency transport to administer charcoal 4, 5, 8, 6

Contraindicated Interventions

  • Never induce emesis with ipecac syrup - no clinical benefit and delays definitive care 2, 3, 4, 5, 8, 6
  • Gastric lavage only justified in rare life-threatening ingestions of substances not adsorbed by charcoal 3
  • Do not give anything by mouth unless specifically directed by poison control (Class III recommendation) 2

Toxin-Specific Antidotes and Management

Acetaminophen Poisoning

  • Administer N-acetylcysteine within 24 hours of ingestion for hepatoprotection, ideally within 8-10 hours 9, 3
  • Obtain plasma acetaminophen concentration no sooner than 4 hours post-ingestion to assess hepatotoxicity risk using the Rumack-Matthew nomogram 9
  • If assay unavailable, assume overdose is potentially toxic and treat empirically 9

Opioid Toxicity

  • Naloxone has shorter duration than most opioids, requiring continuous monitoring and repeated dosing 1, 2, 3
  • Intranasal naloxone 2-4 mg can be repeated every 2-3 minutes as needed 1
  • Naloxone has favorable safety profile and unlikely to cause harm in non-opioid respiratory depression 2

Benzodiazepine Poisoning

  • If combined opioid-benzodiazepine poisoning suspected, administer naloxone first (Class 2a recommendation) 1
  • Flumazenil can reverse pure benzodiazepine-induced respiratory depression in select patients without contraindications 1, 2
  • Flumazenil is contraindicated and causes harm in patients at risk for seizures (chronic benzodiazepine use, seizure disorder, tricyclic antidepressant co-ingestion) 1, 2, 6
  • Flumazenil has no role in cardiac arrest from benzodiazepines 1

Calcium Channel Blocker Poisoning

  • For asymptomatic patients: observe and consider activated charcoal within 1 hour 1
  • For symptomatic/unstable patients: IV calcium bolus, high-dose insulin (1 U/kg bolus, then 1-10 U/kg/h infusion with glucose monitoring), vasopressors 1
  • For cardiac arrest: IV calcium, lipid emulsion therapy (1.5 mL/kg bolus of 20% solution, then 0.25 mL/kg/min), and consider VA-ECMO if available 1

Tricyclic Antidepressant Toxicity

  • Administer sodium bicarbonate (50-150 mEq bolus) for QRS >100 msec, ventricular arrhythmias, or hypotension to overcome sodium channel blockade 1, 6
  • Prepare 150 mEq/L solution and infuse at 1-3 mL/kg/h, monitoring for hypernatremia and alkalemia 1
  • Benzodiazepines for seizures; flumazenil is contraindicated 6

Organophosphate/Carbamate Poisoning

  • Atropine 1-2 mg IV (pediatric: 0.02 mg/kg) for bronchospasm, bronchorrhea, or severe bradycardia, repeated every 5 minutes and titrated to dry secretions 1, 2
  • Pralidoxime 1-2 g IV (pediatric: 20-50 mg/kg) followed by continuous infusion 1
  • Early endotracheal intubation for life-threatening poisoning 2

Anticholinergic Toxicity (Datura)

  • Benzodiazepines first-line for agitation and delirium 10
  • Physostigmine is definitive antidote for severe anticholinergic syndrome with life-threatening symptoms (severe delirium, coma, hyperthermia, refractory seizures) 10

Chemical Exposure Management

Dermal/Ocular Exposure

  • Remove all contaminated clothing immediately and irrigate affected skin with copious water for at least 15 minutes (Class I, Level B-NR) 2
  • Flush eyes with large amounts of water for at least 15 minutes (Class I, Level C) 2
  • Remove chemical powders with gloves before water irrigation 2
  • Never apply neutralizing agents to chemical burns 2

Observation and Disposition Criteria

Emergency Department Referral Indications

  • All cases of intentional self-harm, suicidal ideation, abuse, or malicious intent 4, 5, 8, 6
  • Any patient with more than mild symptoms (altered mental status beyond mild somnolence, cardiovascular instability, respiratory depression) 4, 5, 8, 6
  • Ingestion exceeding toxic dose thresholds for specific agents 4, 5, 8, 6
  • Patients taking MAO inhibitors with any sympathomimetic ingestion 4, 8

Home Observation Criteria

  • Asymptomatic patients with subtoxic ingestions after appropriate observation period (typically 4-6 hours for immediate-release, 12 hours for extended-release formulations) 4, 5, 8, 6
  • Poison center-initiated follow-up calls at 2-4 hour intervals to monitor for symptom development 4, 5, 8, 6

Critical Pitfalls to Avoid

  • Do not delay supportive care while awaiting toxicology results or poison identification - treatment is based on clinical presentation 7, 10
  • Multiple drug exposures are common; maintain broad differential diagnosis 1
  • Recognize toxidromes (anticholinergic, cholinergic, sympathomimetic, sedative-hypnotic, opioid) to guide empiric management 1
  • Do not wait for acetaminophen assay results to begin N-acetylcysteine if access to emergency care not feasible within 8-10 hours 9, 3
  • Consult medical toxicologist or poison center early for potentially life-threatening poisonings to prevent deterioration to cardiac arrest 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Emergency Management of Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ICU Management of Rodenticide Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Datura Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.